Dynavax Technologies
DVAX
DVAX was delisted on the 9th of February, 2026.
117 hedge funds and large institutions have $282M invested in Dynavax Technologies in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 39 reducing their positions, and 12 closing their positions.
292% more call options, than puts
Call options by funds: $1.15M | Put options by funds: $294K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
58% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 12
6% more funds holding
Funds holding: 110 → 117 (+7)
20% less capital invested
Capital invested by funds: $352M → $282M (-$69.8M)
26% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 39
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$4.04M |
| 2 |
AC
Amici Capital
New York
|
+$3M |
| 3 |
Renaissance Technologies
New York
|
+$1.72M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$1.01M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$431K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$11M |
| 2 |
HM
HealthCor Management
New York
|
-$8.67M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$5.8M |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.39M |
| 5 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$2.83M |
DVAX Hedge Fund Activity: Q2 2014 in Review
117 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q2 2014, worth a combined $282M — down 20% from $352M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new DVAX positions and 12 closed out — a net gain of 7 holders — while 29 added to existing stakes and 39 trimmed.
The largest buyer was Clough Capital Partners, opening a new position worth an estimated $4.04M. The largest seller was Fidelity Investments, cutting an estimated $11M.
- 117 institutional investors held Dynavax Technologies (DVAX) as of Q2 2014, up from 110 in Q1 2014.
- Funds reported $282M of Dynavax Technologies stock for Q2 2014, down 20% quarter-over-quarter.
- 19 funds opened new Dynavax Technologies positions in Q2 2014 and 12 closed out, a net change of +7 holders.
- The largest Dynavax Technologies buyer in Q2 2014 was Clough Capital Partners, an estimated $4.04M added.
- The largest Dynavax Technologies seller in Q2 2014 was Fidelity Investments, an estimated $11M sold.
Based on aggregated 13F filings for Q2 2014.